Jacobio Pharmaceuticals Group (JBPHF) Stock Price, News & Analysis

Company Overview

Jacobio Pharmaceuticals Group Co., Ltd. is a China-based biopharmaceutical company engaged in the discovery, development and commercialization of novel therapies for oncology and immuno-oncology indications. The company’s research efforts focus on small‐molecule inhibitors and biologics designed to address solid tumor types including lung, liver and esophageal cancers. Jacobio’s pipeline features multiple preclinical and clinical‐stage candidates targeting specific molecular pathways and tumor microenvironment interactions.

Operating research and development facilities in Shanghai, Jacobio collaborates with academic institutions, contract research organizations and clinical sites across Mainland China. The company has advanced several investigational new drug (IND) applications with Chinese regulatory authorities and is exploring the potential for international clinical trials and regulatory filings in Asia-Pacific markets. Its scientific platform integrates medicinal chemistry, translational biology and immuno-oncology expertise to accelerate candidate selection and development.

Supported by a management team with extensive experience in pharmaceutical R&D, regulatory affairs and strategic alliances, Jacobio Pharmaceuticals is pursuing partnerships and in-licensing opportunities to broaden its therapeutic portfolio. The company aims to bring first-in-class or best-in-class treatments to patients by leveraging its targeted therapy and immunotherapeutic technologies.

Key Stats

• Today's Range: $0.87 to $0.87
• 50-Day Range: $0.30 to $0.87
• 52-Week Range: $0.30 to $0.87
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

JBPHF Stock Analysis - Frequently Asked Questions

How have JBPHF shares performed this year?

Jacobio Pharmaceuticals Group's stock was trading at $0.2950 at the beginning of the year. Since then, JBPHF stock has increased by 193.8% and is now trading at $0.8666.

How do I buy shares of Jacobio Pharmaceuticals Group?

Shares of JBPHF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:JBPHF
• CIK: N/A
• Web: www.jacobiopharma.com
• Phone: 86-10-5631-5466
• Fax: N/A
• Employees: 301
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A